Correlation Between Inozyme Pharma and Alpha Tau
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Alpha Tau at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Alpha Tau into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and Alpha Tau Medical, you can compare the effects of market volatilities on Inozyme Pharma and Alpha Tau and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Alpha Tau. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Alpha Tau.
Diversification Opportunities for Inozyme Pharma and Alpha Tau
0.01 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Inozyme and Alpha is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and Alpha Tau Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alpha Tau Medical and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Alpha Tau. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alpha Tau Medical has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Alpha Tau go up and down completely randomly.
Pair Corralation between Inozyme Pharma and Alpha Tau
Given the investment horizon of 90 days Inozyme Pharma is expected to under-perform the Alpha Tau. In addition to that, Inozyme Pharma is 1.18 times more volatile than Alpha Tau Medical. It trades about -0.07 of its total potential returns per unit of risk. Alpha Tau Medical is currently generating about -0.02 per unit of volatility. If you would invest 332.00 in Alpha Tau Medical on August 28, 2024 and sell it today you would lose (79.00) from holding Alpha Tau Medical or give up 23.8% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inozyme Pharma vs. Alpha Tau Medical
Performance |
| Timeline |
| Inozyme Pharma |
| Alpha Tau Medical |
Inozyme Pharma and Alpha Tau Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inozyme Pharma and Alpha Tau
The main advantage of trading using opposite Inozyme Pharma and Alpha Tau positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Alpha Tau can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alpha Tau will offset losses from the drop in Alpha Tau's long position.| Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. X4 Pharmaceuticals | Inozyme Pharma vs. Acumen Pharmaceuticals | Inozyme Pharma vs. Mereo BioPharma Group |
| Alpha Tau vs. Eliem Therapeutics | Alpha Tau vs. HCW Biologics | Alpha Tau vs. Scpharmaceuticals | Alpha Tau vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |